Advanced Medical Solutions Group Share Price (AMS)

PUSU DEADLINE EXTENSION

My view is that the announcement at 1 pm last Thursday (18 June) of a two-week extension to the "Offer Period", i.e. H.B. Fuller's put-up-or-shut-up ("PUSU") deadline. The annoucement said that discussions between the parties remain ongoing. I'm sure that H.B. Fuller and AMS are heavily engaged in serious takeover negotiations so the news of the extension was a very positive development.

As I said here on 27 May, H.B. Fuller's advisors are Goldman Sachs and Perella Weinberg Partners who are at the top of their game. Taking this and everything else into accout, my view is that the probability of a formal takeover offer is now significantly more than 50/50. Accordingly, I'm not going to sell my AMS shares before the new 2nd July PUSU deadline.

Just before last Thursday's announcement AMS shares were trading at 220.0 to 220.5. Within a minute of the announcement there was an immediate surge in share transactions, particularly buys. There were a few buy transactions at 224, 224.5 and 225, then they traded at about 222 until about 2:30 pm. After that, they started rising and they closed up 1 at 228. The following day, Friday, they closed up 7 at 235.

During an "Offer Period" it's common for the share price of a target company to fall in the absence of substantive news about any fomal offer. Accordingly, I expect the AMS share price to go into reverse until nearer the new PUSU deadline which is 5 pm on Thursday 2 July. Indeed, today AMS closed down 3.5 at 231.5.

It's quite possible that an announcement of a formal offer, or an announcement that HB Fuller have decided to pull out, might be made at any time before the new 2nd July deadline.

H.B. FULLER SECOND QUARTER RESULTS

The possible bidder, H.B. Fuller, reports their 2026 second quarter results this Wednesday, 24 June 2026 - see their website at: https://newsroom.hbfuller.com/press-releases/press-release-details/2026/H-B--Fuller-to-Report-Second-Quarter-2026-Results-on-June-24-2026/default.aspx

mmm

I have never before held a company share that seems constantly to be subjected to takeover speculation which comes to naught as the potential offer places a low valuation in relation to the sp excluding any bid.. It is becoming boring and repetitive ?

Disclosed shorts have covered substantially.

Let’s see if the Sky or betaville fellows dig out more over the weekend.

Medication is readily available for the runs.

I can understand your displeasure in me making a huge turn on Spire but please, others don't wish to hear or need to hear about it. Stick to the topic.

The idiot clown is back. The clown who gets Spire and every special situation wrong. Run guys, run. What an idiot.